본문 바로가기
KERD
논문KCI 등재

Current Management Strategy of Nasopharyngeal Carcinoma

William I. Wei|Dora L. W. Kwong
대한이비인후과학회 (Korean Society of Otorhinolaryngology-Head and Neck Surgery)|2010.03|Clinical and Experimental Otorhinolaryngology|제3권 제1호|pp. 1-12

1

조회

0

다운로드

2

인용

0

참고문헌

키워드

ManagementDiagnosisRadiotherapyChemotherapyNasopharyngeal carcinomaSurgical salvage

초록

Nasopharyngeal carcinoma is an unique head and neck cancer. It is common among the southern Chinese and is closely associated with the Epstein Barr virus (EBV). To diagnose the disease in its early stage is infrequent as the symptoms are usually trivial and patients only present in late stages. Testing the blood for elevated EBV DNA has now become a screening test for the high risk group of patients, aiming to diagnose the disease in its early stages. Imaging studies, positron emission tomography scans in addition to clinical examination provide information on the extent of the disease. The confirmation of the disease still depends on endoscopic examination and biopsy. Radiotherapy with or without chemotherapy has been the primary treatment modality. The application of intensity modulated radiotherapy and the use of concomitant chemoradiation have improved the control of nasopharyngeal carcinoma together with the reduction of long term side effects. The early detection of residual or recurrence tumor in the neck or at the primary site has allowed delivery of salvage treatment. The choice of the optimal surgical salvage, either for neck disease or primary tumor depends on the extent of the residual or recurrent disease. The outcome of these patients have improved with the application of the appropriate surgical salvage.

Abstract

Nasopharyngeal carcinoma is an unique head and neck cancer. It is common among the southern Chinese and is closely associated with the Epstein Barr virus (EBV). To diagnose the disease in its early stage is infrequent as the symptoms are usually trivial and patients only present in late stages. Testing the blood for elevated EBV DNA has now become a screening test for the high risk group of patients, aiming to diagnose the disease in its early stages. Imaging studies, positron emission tomography scans in addition to clinical examination provide information on the extent of the disease. The confirmation of the disease still depends on endoscopic examination and biopsy. Radiotherapy with or without chemotherapy has been the primary treatment modality. The application of intensity modulated radiotherapy and the use of concomitant chemoradiation have improved the control of nasopharyngeal carcinoma together with the reduction of long term side effects. The early detection of residual or recurrence tumor in the neck or at the primary site has allowed delivery of salvage treatment. The choice of the optimal surgical salvage, either for neck disease or primary tumor depends on the extent of the residual or recurrent disease. The outcome of these patients have improved with the application of the appropriate surgical salvage.

참고문헌 (152)

  1. Jackson C, "Primary carcinoma of the nasopharynx:a table of cases", J Am Med Assoc, 37(6), pp.371~377 (1901)
  2. Digby KH, "Nasopharyngeal carcinoma", Br J Surg, 28(112), pp.517~537 (1941)
  3. Loh LE, "The anatomy of the Fossa of Rosenmuller:its possible influence on the detection of occult nasopharyngeal carcinoma", Singapore Med J, 32(3), pp.154~155 (1991)
  4. Sham JS, "Detection of subclinical nasopharyngeal carcinoma by fibreoptic endoscopy and multiple biopsy", Lancet, 335(8686), pp.371~374 (1990)
  5. Parkin DM, "Cancer Incidence in Five Continents, Vol. VII. IARC Scientific Publications No. 143", pp.814~815 (1997), International Agency for Research on Cancer
  6. Nielsen NH, "Nasopharyngeal cancer in Greenland:the incidence in an Arctic Eskimo population", Acta Pathol Microbiol Scand A, 85(6), pp.850~858 (1977)
  7. Dickson RI, "Nasopharyngeal carcinoma:an evaluation of 134 patients treated between 1971-1980", Laryngoscope, 95(3), pp.276~283 (1985)
  8. Buell P, "The effect of migration on the risk of nasopharyngeal cancer among Chinese", Cancer Res, 34(5), pp.1189~1191 (1974)
  9. Lee AW, "Nasopharyngeal carcinoma:presenting symptoms and duration before diagnosis", Hong Kong Med J, 3(4), pp.355~361 (1997)
  10. Ozyar E, "Cranial nerve involvement in nasopharyngeal carcinoma:its prognostic role and response to radiotherapy", Radiat Med, 12(2), pp.65~68 (1994)
  11. Sham JS, "Nasopharyngeal carcinoma in young patients", Cancer, 65(11), pp.2606~2610 (1990)
  12. Godtfredsen E, "Chapter III: on the histopathology of malignant nasopharyngeal tumours", Acta Pathol Microbiol Scand, 32(Suppl 59), pp.38~56 (1944)
  13. Svoboda D, "Ultrastructure of nasopharyngeal carcinomas in American and Chinese patients,an application of electron microscopy to geographic pathology", Exp Mol Pathol, 28, pp.189~204 (1965)
  14. Prasad U, "Cells of origin of nasopharyngeal carcinoma:an electron microscopic study", J Laryngol Otol, 88(11), pp.1087~1094 (1974)
  15. Shanmugaratnamm K, "International histological classification of tumours: No. 19. 2nd ed" (1991), World Health Organization
  16. Micheau C, "Proposal for a new histopathological classification of the carcinomas of the nasopharynx", Tumori, 64(5), pp.513~518 (1978)
  17. Reddy SP, "Prognostic significance of keratinization in nasopharyngeal carcinoma", Am J Otolaryngol, 16(2), pp.103~108 (1995)
  18. Marks JE, "The National Cancer Data Base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma", Cancer, 83(3), pp.582~588 (1998)
  19. Nicholls JM, "Nasopharyngeal carcinoma:classification and histological appearances", Adv Anat Pathol., 4(2), pp.71~84 (1997)
  20. GulleyML, "Molecular diagnosis of Epstein-Barr virus-related diseases", J Mol Diagn, 3(1), pp.1~10 (2001)
  21. Zeng Y, "Prospective studies on nasopharyngeal carcinoma in Epstein-Barr virus IgA", VCA antibody-positive persons in Wuzhou City,China, 1985, pp.36(5), 545~547
  22. Chien YC, "Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men", N Engl J Med, 345(26), pp.1877~1882 (2001)
  23. Mutirangura A, "Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma", Clin Cancer Res, 4(3), pp.665~669 (1998)
  24. Lo YM, "Kinetics of plasma Epstein-Barr virus DNA during radiation therapy for nasopharyngeal carcinoma", Cancer Res, 60(9), pp.2351~2355 (2000)
  25. Hong RL, "Comparison of clinical and molecular surveillance in patients with advanced nasopharyngeal carcinoma after primary therapy:the potential role of quantitative analysis of circulating Epstein-Barr virus DNA", Cancer, 100(7), pp.1429~1437 (2004)
  26. Lin JC, "Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma", N Engl J Med, 350(24), pp.2461~2470 (2004)
  27. Leung SF, "Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type", Cancer, 98(2), pp.288~291 (2003)
  28. Chan AT, "Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma", J Natl Cancer Inst, 94(21), pp.1614~1619 (2002)
  29. Leung SF, "Improved accuracy of detection of nasopharyngeal carcinoma by combined application of circulating Epstein-Barr virus DNA and anti-Epstein-Barr viral capsid antigen IgA antibody", Clin Chem, 50(2), pp.339~345 (2004)
  30. WeiWI, "Quantitative analysis of plasma cell-free Epstein-Barr virus DNA in nasopharyngeal carcinoma after salvage nasopharyngectomy:a prospective study", Head Neck, 26(10), pp.878~883 (2004)
  31. Sham JS, "Nasopharyngeal carcinoma:CT evaluation of patterns of tumor spread", AJNR Am J Neuroradiol, 12(2), pp.265~270 (1991)
  32. Chong VF, "Nasopharyngeal carcinoma with intracranial spread:CT and MR characteristics", J Comput Assist Tomogr, 20(4), pp.563~569 (1996)
  33. Dillon WP, "Magnetic resonance imaging of the nasopharynx", Radiology, 152(3), pp.731~738 (1984)
  34. Cheng SH, "Prognostic features and treatment outcome in locoregionally advanced nasopharyngeal carcinoma following concurrent chemotherapy and radiotherapy", Int J Radiat Oncol Biol Phys, 41(4), pp.755~762 (1998)
  35. Olmi P, "Staging and follow-up of nasopharyngeal carcinoma:magnetic resonance imaging versus computerized tomography", Int J Radiat Oncol Biol Phys, 32(3), pp.795~800 (1995)
  36. Sham JS, "Role of bone scanning in detection of subclinical bone metastasis in nasopharyngeal carcinoma", Clin Nucl Med, 16(1), pp.27~29 (1991)
  37. Kraiphibul P, "Nasopharyngeal carcinoma:value of bone and liver scintigraphy in the pre-treatment and follow-up period", J Med Assoc Thai, 74(7), pp.276~279 (1991)
  38. Leung SF, "Staging abdominal ultrasonography in nasopharyngeal carcinoma", Australas Radiol, 35(1), pp.31~32 (1991)
  39. Sham JS, "Nasopharyngeal carcinoma:role of marrow biopsy at diagnosis", Oncology, 48(6), pp.480~482 (1991)
  40. Nakamoto Y, "Prevalence and patterns of bone metastases detected with positron emission tomography using F-18 FDG", Clin Nucl Med, 28(4), pp.302~307 (2003)
  41. Yen RF, "18-fluoro-2-deoxyglucose positron emission tomography in detecting residual", recurrent nasopharyngeal carcinomas and comparison with magnetic resonance imaging, 2003, pp.98(2), 283~287
  42. Cellai E, "Computed tomography in nasopharyngeal carcinoma:Part II:Im-pact on survival", Int J Radiat Oncol Biol Phys, 19(5), pp.1177~1182 (1990)
  43. Emami B, "Influence of MRI on target volume delineation and IMRT planning in nasopharyngeal carcinoma", Int J Radiat Oncol Biol Phys, 57(2), pp.481~488 (2003)
  44. Sobin LH, "TNM classification of malignant tumours. 5th ed", pp.227~ (1997), Wiley-Liss
  45. Ho JH, "An epidemiologic and clinical study of nasopharyngeal carcinoma", Int J Radiat Oncol Biol Phys, 4(3-4), pp.182~198 (1978)
  46. Ho JH, "Stage classification of nasopharyngeal carcinoma:a review", IA RC Sci Publ., (20), pp.99~113 (1978)
  47. Sham JS, "Cranial nerve involvement and base of the skull erosion in nasopharyngeal carcinoma", Cancer, 68(2), pp.422~426 (1991)
  48. Chua DT, "Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma:a significant factor in local control and distant metastasis", Cancer, 78(2), pp.202~210 (1996)
  49. Teo P, "Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography", Int J Radiat Oncol Biol Phys, 36(2), pp.291~304 (1996)
  50. Fleming ID, "AJCC cancer staging manual", pp.294~ (1997), Lippincott- Raven
  51. Lee AW, "Staging of nasopharyngeal carcinoma:from Ho’s to the new UICC system", Int J Cancer, 84(2), pp.179~187 (1999)
  52. Cooper JS, "A comparison of staging systems for nasopharyngeal carcinoma", Cancer, 83(2), pp.213~219 (1998)
  53. Ozyar E, "Comparison of AJCC 1988 and 1997 classifications for nasopharyngeal carcinoma.American Joint Committee on Cancer", Int J Radiat Oncol Biol Phys, 44(5), pp.1079~1087 (1999)
  54. Perez CA, "Carcinoma of the nasopharynx:factors affecting prognosis", Int J Radiat Oncol Biol Phys., 23(2), pp.271~280 (1992)
  55. Sham JS, "Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma on local control and short-term survival", Head Neck, 13(4), pp.298~310 (1991)
  56. Chua DT, "Volumetric analysis of tumor extent in nasopharyngeal carcinoma and correlation with treatment outcome", Int J Radiat Oncol Biol Phys, 39(3), pp.711~719 (1997)
  57. Chang CC, "The effect of primary tumor volumes in advanced T-staged nasopharyngeal tumors", Head Neck, 24(10), pp.940~946 (2002)
  58. Sze WM, "Primary tumor volume of nasopharyngeal carcinoma:prognostic significance for local control", Int J Radiat Oncol Biol Phys, 59(1), pp.21~27 (2004)
  59. Lo YM, "Quantitative analysis of Epstein-Barr virus DNA in plasma and serum:applications to tumor detection and monitoring", Ann N Y Acad Sci, 945, pp.68~72 (2001)
  60. Chua DT, "The predictive value of the 1997 American Joint Committee on Cancer stage classification in determining failure patterns in nasopharyngeal carcinoma", Cancer, 92(11), pp.2845~2855 (2001)
  61. Mesic JB, "Megavoltage irradiation of epithelial tumors of the nasopharynx", Int J Radiat Oncol Biol Phys, 7(4), pp.447~453 (1981)
  62. Hoppe RT, "Carcinoma of the nasopharynx:eighteen years’ experience with megavoltage radiation therapy", Cancer, 37(6), pp.2605~2612 (1976)
  63. Lee AW, "Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985:overall survival and patterns of failure", Int J Radiat Oncol Biol Phys., 23(2), pp.261~270 (1992)
  64. Wang CC, "Improved local control of nasopharyngeal carcinoma after intracavitary brachytherapy boost", Am J Clin Oncol, 14(1), pp.5~8 (1991)
  65. Kwong DL, "The effect of interruptions and prolonged treatment time in radiotherapy for nasopharyngeal carcinoma", Int J Radiat Oncol Biol Phys, 39(3), pp.703~710 (1997)
  66. Lee AW, "Treatment of stage I nasopharyngeal carcinoma:analysis of the patterns of relapse and the results of withholding elective neck irradiation", Int J Radiat Oncol Biol Phys, 17(6), pp.1183~1190 (1989)
  67. Kwong D, "The effect of loco-regional control on distant metastatic dissemination in carcinoma of the nasopharynx:an analysis of 1301 patients", Int J Radiat Oncol Biol Phys, 30(5), pp.1029~1036 (1994)
  68. Levendag PC, "High-dose,high-precision treatment options for boosting cancer of the nasopharynx", Radiother Oncol, 63(1), pp.67~74 (2002)
  69. Le QT, "Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma", Int J Radiat Oncol Biol Phys, 56(4), pp.1046~1054 (2003)
  70. Chua DT, "Linear accelerator-based stereotactic radiosurgery for limited,locally persistent,and recurrent nasopharyngeal carcinoma:efficacy and complications", Int J Radiat Oncol Biol Phys, 56(1), pp.177~183 (2003)
  71. Waldron J, "Limitation of conventional two dimensional radiation therapy planning in nasopharyngeal carcinoma", Radiother Oncol, 68(2), pp.153~161 (2003)
  72. Cheng JC, "Comparison of intensity modulated radiation therapy(IMRT)treatment techniques for nasopharyngeal carcinoma", Int J Cancer, 96(2), pp.126~131 (2001)
  73. Wu VW, "Target dose conformity in 3-dimensional conformal radiotherapy and intensity modulated radiotherapy", Radiother Oncol, 71(2), pp.201~206 (2004)
  74. Hsiung CY, "Intensity-modulated radiotherapy versus conventional three-dimensional conformal radiotherapy for boost or salvage treatment of nasopharyngeal carcinoma", Int J Radiat Oncol Biol Phys, 53(3), pp.638~47 (2002)
  75. Withers HR, "Dose fractionation and volume effects in normal tissues and tumors", Am J Clin Oncol, 11(3), pp.313~329 (1988)
  76. Butler EB, "Smart(simultaneous modulated accelerated radiation therapy)boost:a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy", Int J Radiat Oncol Biol Phys, 45(1), pp.21~32 (1999)
  77. Lee N, "Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma:an update of the UCSF experience", Int J Radiat Oncol Biol Phys, 53(1), pp.12~22 (2002)
  78. Wolden SL, "Intensity-modulated radiation therapy(IMRT)for nasopharynx cancer:update of the Memorial Sloan-Kettering experience", Int J Radiat Oncol Biol Phys, 64(1), pp.57~62 (2006)
  79. Kam MK, "Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy:the Hong Kong experience", Int J Radiat Oncol Biol Phys, 60(5), pp.1440~1450 (2004)
  80. Kwong DL, "Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma:a prospective study on disease control and preservation of salivary function", Cancer, 101(7), pp.1584~1593 (2004)
  81. Tham IW, "Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy-the national cancer centre singapore experience", Int J Radiat Oncol Biol Phys, 75(5), pp.1481~1486 (2009)
  82. Kwong DL, "Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma", Int J Radiat Oncol Biol Phys, 64(2), pp.374~381 (2006)
  83. Pow EH, "Xerostomia and quality of life after intensity-modulated radiotherapy vs.conventional radiotherapy for early-stage nasopharyngeal carcinoma:initial report on a randomized controlled clinical trial", Int J Radiat Oncol Biol Phys, 66(4), pp.981~991 (2006)
  84. Kam MK, "Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients", J Clin Oncol, 25(31), pp.4873~4879 (2007)
  85. McMillan AS, "Preservation of quality of life after intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma:results of a prospective longitudinal study", Head Neck, 28(8), pp.712~722 (2006)
  86. Lee N, "Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma:radiation therapy oncology group phase II trial 0225", J Clin Oncol, 27(22), pp.3684~3690 (2009)
  87. Rossi A, "Adjuvant chemotherapy with vincristine,cyclophosphamide,and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer:results of a 4-year multicenter randomized study", J Clin Oncol, 6(9), pp.1401~1410 (1988)
  88. Harrison LB, "Chemotherapy as part of the initial treatment for nasopharyngeal cancer", Oncology(Williston Park), 5(2), pp.67~70 (1991)
  89. Turner SL, "Synchronous radiotherapy and chemotherapy in the treatment of nasopharyngeal carcinoma", Int J Radiat Oncol Biol Phys, 27(2), pp.371~377 (1993)
  90. Chan AT, "A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma", Int J Radiat Oncol Biol Phys, 33(3), pp.569~577 (1995)
  91. Teo PM, "A retrospective study of the use of cisplatinum-5-fluorouracil neoadjuvant chemotherapy in cervical-node-positive nasopharyngeal carcinoma (NPC)", Eur J Cancer B Oral Oncol, 31B(6), pp.373~379 (1995)
  92. "Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV(> or = N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival. International Nasopharynx Cancer Study Group. VUMCA I trial", Int J Radiat Oncol Biol Phys, 35(3), pp.463~469 (1996)
  93. Garden AS, "Does induction chemotherapy have a role in the management of nasopharyngeal carcinoma? Results of treatment in the era of computerized tomography", Int J Radiat Oncol Biol Phys, 36(5), pp.1005~1012 (1996)
  94. Lin JC, "Partially hyperfractionated accelerated radiotherapy and concurrent chemotherapy for advanced nasopharyngeal carcinoma", Int J Radiat Oncol Biol Phys, 36(5), pp.1127~1136 (1996)
  95. Al-Sarraf M, "Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer:phase III randomized Intergroup study 0099", J Clin Oncol, 16(4), pp.1310~1317 (1998)
  96. Chua DT, "Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma:Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group", Cancer, 83(11), pp.2270~2283 (1998)
  97. Lee AW, "Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group", J Clin Oncol, 23(28), pp.6966~6975 (2005)
  98. Wee J, "Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer", International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety, 2005, pp.23(27), 6730~6738
  99. Chen Y, "Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china", Int J Radiat Oncol Biol Phys, 71(5), pp.1356~1364 (2008)
  100. Baujat B, "Chemotherapy in locally advanced nasopharyngeal carcinoma:an individual patient data meta-analysis of eight randomized trials and 1753 patients", Int J Radiat Oncol Biol Phys, 64(1), pp.47~56 (2006)
  101. Kwong DL, "Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma:a factorial study", J Clin Oncol, 22(13), pp.2643~2653 (2004)
  102. Chi KH, "A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients", Int J Radiat Oncol Biol Phys, 52(5), pp.1238~1244 (2002)
  103. Fang FM, "Health-related quality of life for nasopharyngeal carcinoma patients with cancer-free survival after treatment", Int J Radiat Oncol Biol Phys, 53(4), pp.959~968 (2002)
  104. McMillan AS, "Oral health-related quality of life in southern Chinese following radiotherapy for nasopharyngeal carcinoma", J Oral Rehabil, 31(6), pp.600~608 (2004)
  105. HoWK, "Longterm sensorineural hearing deficit following radiotherapy in patients suffering from nasopharyngeal carcinoma:a prospective study", Head Neck, 21(6), pp.547~553 (1999)
  106. Lam KS, "Effects of cranial irradiation on hypothalamic-pituitary function:a 5-year longitudinal study in patients with nasopharyngeal carcinoma", Q J Med, 78(286), pp.165~176 (1991)
  107. Pow EH, "Salivary gland function and xerostomia in southern Chinese following radiotherapy for nasopharyngeal carcinoma", Clin Oral Investig, 7(4), pp.230~234 (2003)
  108. Pow EH, "Oral health condition in southern Chinese after radiotherapy for nasopharyngeal carcinoma:extent and nature of the problem", Oral Dis, 9(4), pp.196~202 (2003)
  109. Leung SF, "Quan-titative measurement of post-irradiation neck fibrosis based on the young modulus:description of a new method and clinical results", Cancer, 95(3), pp.656~662 (2002)
  110. Cheng SW, "Carotid stenosis after radiotherapy for nasopharyngeal carcinoma", Arch Otolaryngol Head Neck Surg, 126(4), pp.517~521 (2000)
  111. Lee AW, "Factors affecting risk of symptomatic temporal lobe necrosis:significance of fractional dose and treatment time", Int J Radiat Oncol Biol Phys, 53(1), pp.75~85 (2002)
  112. Lin YS, "Radiation-related cranial nerve palsy in patients with nasopharyngeal carcinoma", Cancer, 95(2), pp.404~409 (2002)
  113. Chang YC, "Dysphagia in patients with nasopharyngeal cancer after radiation therapy:a videofluoroscopic swallowing study", Dysphagia, 18(2), pp.135~143 (2003)
  114. Lam LC, "Progress of memory function after radiation therapy in patients with nasopharyngeal carcinoma", J Neuropsychiatry Clin Neurosci, 15(1), pp.90~97 (2003)
  115. Cheung M, "Cognitive function of patients with nasopharyngeal carcinoma with and without temporal lobe radionecrosis", Arch Neurol, 57(9), pp.1347~1352 (2000)
  116. Lee PW, "Effects of radiation therapy on neuropsychological functioning in patients with nasopharyngeal carcinoma", J Neurol Neurosurg Psychiatry, 52(4), pp.488~492 (1989)
  117. Lee AW, "Retrospective analysis of nasopharyngeal carcinoma treated during 1976-1985:late complications following megavoltage irradiation", Br J Radiol, 65(778), pp.918~928 (1992)
  118. Sham J, "Radiotherapy for nasopharyngeal carcinoma:shielding the pituitary may improve therapeutic ratio", Int J Radiat Oncol Biol Phys, 29(4), pp.699~704 (1994)
  119. Kao CH, "Comparing 18-fluoro-2-deoxyglucose positron emission tomography with a combination of technetium 99m tetrofosmin single photon emission computed tomography and computed tomography to detect recurrent or persistent nasopharyngeal carcinomas after radiotherapy", Cancer, 92(2), pp.434~439 (2001)
  120. Wei WI, "Pathological basis of surgery in the management of postradiotherapy cervical metastasis in nasopharyngeal carcinoma", Arch Otolaryngol Head Neck Surg, 118(9), pp.923~929 (1992)
  121. Chua DT, "Treatment outcome for synchronous locoregional failures of nasopharyngeal carcinoma", Head Neck, 25(7), pp.585~594 (2003)
  122. Huang SC, "Nasopharyngeal cancer:study III.A review of 1206 patients treated with combined modalities", Int J Radiat Oncol Biol Phys, 11(10), pp.1789~1793 (1985)
  123. Sham JS, "Nasopharyngeal carcinoma:treatment of neck node recurrence by radiotherapy", Australas Radiol, 35(4), pp.370~373 (1991)
  124. Wei WI, "Efficacy of radical neck dissection for the control of cervical metastasis after radiotherapy for nasopharyngeal carcinoma", Am J Surg, 160(4), pp.439~442 (1990)
  125. WeiWI, "Management of extensive cervical nodal metastasis in nasopharyngeal carcinoma after radiotherapy:a clinicopathological study", Arch Otolaryngol Head Neck Surg, 127(12), pp.1457~1462 (2001)
  126. Lee AW, "Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976-1985:survival after local recurrence", Int J Radiat Oncol Biol Phys, 26(5), pp.773~782 (1993)
  127. Xiao J, "Fractionated stereotactic radiosurgery for 50 patients with recurrent or residual nasopharyngeal carcinoma", Int J Radiat Oncol Biol Phys, 51(1), pp.164~170 (2001)
  128. Wang CC, "A simple afterloading applicator for intracavitary irradiation of carcinoma of the nasopharynx", Radiology, 115(3), pp.737~738 (1975)
  129. Harrison LB, "A technique for interstitial nasopharyngeal brachytherapy", Int J Radiat Oncol Biol Phys, 13(3), pp.451~453 (1987)
  130. Wei WI, "Split-palate approach for gold grain implantation in nasopharyngeal carcinoma", Arch Otolaryngol Head Neck Surg, 116(5), pp.578~582 (1990)
  131. Choy D, "Transpalatal insertion of radioactive gold grain for the treatment of persistent and recurrent nasopharyngeal carcinoma", Int J Radiat Oncol Biol Phys, 25(3), pp.505~512 (1993)
  132. Kwong DL, "Long term results of radioactive gold grain implantation for the treatment of persistent and recurrent nasopharyngeal carcinoma", Cancer, 91(6), pp.1105~1113 (2001)
  133. Leung TW, "High dose rate intracavitary brachytherapy in the treatment of nasopharyngeal carcinoma", Acta Oncol., 35(1), pp.43~47 (1996)
  134. Law SC, "Reirradiation of nasopharyngeal carcinoma with intracavitary mold brachytherapy:an effective means of local salvage", Int J Radiat Oncol Biol Phys, 54(4), pp.1095~1113 (2002)
  135. Fisch U, "The infratemporal fossa approach for nasopharyngeal tumors", Laryngoscope, 93(1), pp.36~44 (1983)
  136. Fee WE Jr, "Long-term survival after surgical resection for recurrent nasopharyngeal cancer after radiotherapy failure", Arch Otolaryngol Head Neck Surg, 117(11), pp.1233~1236 (1991)
  137. Morton RP, "Transcervico-mandibulo-palatal approach for surgical salvage of recurrent nasopharyngeal cancer", Head Neck, 18(4), pp.352~358 (1996)
  138. Wei WI, "New approach to the nasopharynx:the maxillary swing approach", Head Neck, 13(3), pp.200~207 (1991)
  139. Wei WI, "Cancer of the nasopharynx:functional surgical salvage", World J Surg, 27(7), pp.844~848 (2003)
  140. Ng RW, "Elimination of palatal fistula after the maxillary swing procedure", Head Neck, 27(7), pp.608~612 (2005)
  141. Fee WE Jr, "Nasopharyngectomy for recurrent nasopharyngeal cancer:a 2-to 17-year follow-up", Arch Otolaryngol Head Neck Surg, 128(3), pp.280~284 (2002)
  142. WeiWI, "Nasopharyngeal cancer:current status of management:a New York Head and Neck Society lecture", Arch Otolaryngol Head Neck Surg, 127(7), pp.766~769 (2001)
  143. Roh JL, "Transpalatal endoscopic resection of residual nasopharyngeal carcinoma after sequential chemoradiotherapy", J Laryngol Otol, 118(12), pp.951~954 (2004)
  144. Chen MY, "Endoscopic nasopharyngectomy for locally recurrent nasopharyngeal carcinoma", Laryngoscope, 119(3), pp.516~522 (2009)
  145. Chen MK, "Minimally invasive endoscopic nasopharyngectomy in the treatment of recurrent T1-2a nasopharyngeal carcinoma", Laryngoscope, 117(5), pp.894~896 (2007)
  146. Leung TW, "Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma", Int J Radiat Oncol Biol Phys, 48(5), pp.1331~1338 (2000)
  147. Poon D, "Concurrent chemoradiotherapy in locoregionally recurrent nasopharyngeal carcinoma", Int J Radiat Oncol Biol Phys, 59(5), pp.1312~1318 (2004)
  148. Chua DT, "Re-irradiation of nasopha-ryngeal carcinoma with intensity-modulated radiotherapy", Radiother Oncol, 77(3), pp.290~294 (2005)
  149. Cheng SH, "Longterm survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy", Int J Radiat Oncol Biol Phys, 48(5), pp.1323~1330 (2000)
  150. Pignon JP, "Meta-analysis of chemotherapy in head and neck cancer(MACH-NC):an update on 93 randomised trials and 17,346 patients", Radiother Oncol, 92(1), pp.4~14 (2009)
  152. [URL]

관련 논문AI추천

Individualized Concurrent Chemotherapy for Patients with Stage III–IVa Nasopharyngeal Carcinoma Receiving Neoadjuvant Chemotherapy Combined with Definitive Intensity-Modulated RadiotherapyCheng Lin, Jingfeng Zong, Pengjie Ji, Qiongjiao Lu, Shaojun Lin, Xiane Peng, Xiaoqiang Chen, Yuebing Chen, Zhiwei Chen대한암학회 · Cancer Research and Treatment2023 · 제55권 제4호Combination of Tumor Volume and Epstein-Barr Virus DNA Improved Prognostic Stratification of Stage II Nasopharyngeal Carcinoma in the Intensity Modulated Radiotherapy Era: A Large-Scale Cohort StudyBo-Lin Chen, Chao-Nan Qian, Chong Zhao, Dong-Hua Luo, Hai-Qiang Mai, Hao-Yuan Mo, Ka-Jia Cao, Ling Guo, Lin-Quan Tang, Li-Ting Liu, Meng-Sha Zou, Mu-Sheng Zeng, Qing-Nan Tang, Qiu-Yan Chen, Qi-Yu Zhong, Rui Sun, Shan-Shan Guo, Shao-Yan Guo, Tong-Yu Lu, Wen-Hui Chen, Xiang Guo, Yang Li대한암학회 · Cancer Research and Treatment2018 · 제50권 제3호Patterns of Failure and Survival Trends in 3,808 Patients with Stage II Nasopharyngeal Carcinoma Diagnosed from 1990 to 2012: A Large-Scale Retrospective Cohort StudyDi-Han Liu, Hai-Qiang Mai, Hao-Jun Xie, Jin-Jie Yan, Jun Ma, Lin-Quan Tang, Li-Ting Liu, Ming-Huang Hong, Qing-Nan Tang, Qiu-Yan Chen, Sai-Lan Liu, Shan-Shan Guo, Xiao-Yun Li, Xue-Song Sun, Yue-Feng Wen, Yu-Jing Liang대한암학회 · Cancer Research and Treatment2019 · 제51권 제4호Subdivision of Nasopharyngeal Carcinoma Patients with Bone-Only Metastasis at Diagnosis for Prediction of Survival and Treatment GuidanceHai-Qiang Mai, Hao-Jun Xie, Jin-Jie Yan, Lin-Quan Tang, Li-Ting Liu, Qing-Nan Tang, Qiu-Yan Chen, Sai-Lan Liu, Shan-Shan Guo, Xiao-Yun Li, Xue-Song Sun, Yue-Feng Wen, Yu-Jing Liang대한암학회 · Cancer Research and Treatment2019 · 제51권 제4호Radiation Therapy Combined with (or without) Cisplatin-based Chemotherapy for Patients with Nasopharyngeal Cancer: 15-years Experience of a Single Institution in Korea강진형, 김민식, 김범수, 김연실, 김훈교, 문성권, 선동일, 유은정, 윤세철, 이연수, 정소령, 정수미, 조승호대한암학회 · Cancer Research and Treatment2008 · 제40권 제4호Long-term Survivals, Toxicities and the Role of Chemotherapy in Early-Stage Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiation Therapy: A Retrospective Study with 15-Year Follow-upBoyu Chen, Chong Zhao, Fei Han, Huageng Huang, Jingjing Miao, Lin Wang, Manyi Zhu, Shaomin Huang, Weiwei Xiao, Weixiong Xia, Xiang Guo, Xiaowu Deng, Xiao Xiao, Xing Lv, Yanqun Xiang, Yinglin Peng, Yingshan Liang대한암학회 · Cancer Research and Treatment2022 · 제54권 제1호

이 간행물의 다른 논문 (10건)

Effect of Nebulized Bovine Surfactant for Experimental Otitis Media with Effusion최정욱, 조용범, 오승은, 최철희, 장철호, Haekyun Park, MDpp. 13-17Expression of HSP70 and Its Relation with Other Cytokines in Human Middle Ear Effusion여상원, 이동희, 박경호, 신지현, 최혁기, 장기홍, 박시내pp. 18-23Classification of External Auditory Canal Cholesteatoma by Computed Tomography신승호, 이호기, 심재한pp. 24-26Sex Differences in a Cross Sectional Study of Age-related Hearing Loss in Korean김성희, 박준호, 김학수, 임은정, 이상흔, 장순석pp. 27-31Assessment of Allergic Rhinitis Websites in Korea장문영, 민양기, 문일준, 한두희, 이재서, 김동영, 이철희, 김승태pp. 32-36
원문 보기